Kagatan, Kurt Russel P.
HRN: 22-70-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/30/2024
09/05/2024
IV
150mg
Q8
Infectious Diarrhea
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes